11-21-2018 10:38 AM CET - Health & Medicine
Print

Anti-Nuclear Antibody (ANA) Test Market Outlook 2018 with Global Analysis and Forecasting Industry Study of Alere, Bio-Rad Laboratories, Thermo Fisher Scientific, Trinity Biotech, Antibodies Inc., EUROIMMUN AG, and Immuno Concepts

Press release from: Data Bridge Market Research
Anti-Nuclear Antibody (ANA) Test Market
Anti-Nuclear Antibody (ANA) Test Market


Antinuclear antibody test market report is in-depth study on how the status is for the Pharmaceutical industry. This report includes a study of marketing and development strategies, along with the product portfolios of the leading companies. It also includes profiles of leading companies and brands that are driving the market with their recent developments, product launches, joint ventures, merges, and accusations.

The global antinuclear antibody test market report also gives a deep knowledge about market definition, classifications, applications, engagements, industry size, share & revenue and market trends while also showing the CAGR figures for the Forecast years 2018-2025. SWOT analysis is used to find the market drivers and restrains.

Download PDF Sample Copy of Report @: databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Top Companies Analysis:

The global anti-nuclear antibody test market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. In 2017, the global anti-nuclear antibody test market is dominated by Alere, Inc., followed by Bio-Rad Laboratories and Thermo Fisher Scientific, Inc. Other players in this market include are Trinity Biotech, Antibodies Inc., EUROIMMUN AG, and Immuno Concepts among others.

ALERE, INC.:

Founded in 2001 and headquartered in Massachusetts, U.S. Alere Inc. operates in rapid diagnostics tests devices. Alere segments are focused on cardiometabolic, infectious disease, and toxicology testing. Alere Inc. offers wide range of diagnostic tests for cardiometabolic disease, and toxicology in the United States and across the globe. The products offered by the company includes rapid diagnostic test systems for diagnosis of point-of-care analyzers and test cassette systems for the blood cholesterol, glucose, and related lipids tests and over-the-counter tests for cholesterol monitoring; blood analysis systems for blood gas, electrolyte, and metabolite testing. The anti-nuclear antibody test products are offered by the test and instruments categories.

Abbott Laboratories acquired Alere which has significantly expanded Abbott’s global diagnostics presence. Alere is operating as a subsidiary of Abbott Laboratories.

BIO-RAD LABORATORIES:

Bio-Rad Laboratories, Inc. founded in 1952 and headquartered in California, U.S. It is engaged in development and production of specialty chemicals used in biochemical, pharmaceutical and other life science research applications. It operates its business through its two business segments life science and clinical diagnostics.

Life Science segment offers the wide range of instruments, software, consumables, reagents, and content for the growing fields of cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education.

Clinical Diagnostics offers the wide range of innovative products to clinical laboratories worldwide. It has its global presence in over 35 countries.

Any specific requirements are you looking for? Ask to your Industry Experts @ databridgemarketresearch.com/inquire-before-buying/?dbmr=...

TABLE OF CONTENTS GLOBAL ANTI-NUCLEAR ANTIBODY TEST MARKET

Chapter 1. INTRODUCTION

Chapter 2. MARKET SEGMENTATION

Chapter 3. MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES

Chapter 4. EXECUTIVE SUMMARY

Chapter 5. PREMIUM INSIGHTS

Chapter 6. GLOBAL ANTI-NUCLEAR ANTIBODY TEST MARKET, BY PRODUCT

6.1. OVERVIEW
6.2. ASSAY KITS & REAGENTS
6.3. SYSTEMS
6.4. SOFTWARE

Chapter 7. GLOBAL ANTI-NUCLEAR ANTIBODY TEST MARKET, BY TEST

7.1. OVERVIEW
7.2. INDIRECT IMMUNOFLUORESCENCE
7.3. ELISA
7.4. MULTIPLEX TESTING

Chapter 8. GLOBAL ANTI-NUCLEAR ANTIBODY TEST MARKET, BY DISEASE

8.1. OVERVIEW
8.2. RHEUMATOID ARTHRITIS
8.3. SYSTEMIC LUPUS ERYTHEMATOSUS
8.4. SJÖGREN’S SYNDROME
8.5. SCLERODERMA
8.6. POLYMYOSITIS
8.7. OTHERS

Chapter 9. GLOBAL ANTI-NUCLEAR ANTIBODY TEST MARKET, BY END USER

9.1. OVERVIEW
9.2. HOSPITALS
9.3. CLINICS
9.4. PHYSICIAN OFFICE LABORATORIES
9.5. OTHERS

Chapter 10. GLOBAL ANTI-NUCLEAR ANTIBODY TEST MARKET, BY GEOGRAPHY
10.1. OVERVIEW
10.2. NORTH AMERICA
10.3. EUROPE
10.4. ASIA-PACIFIC
10.5. SOUTH AMERICA
10.6. MIDDLE EAST & AFRICA

Chapter 11. GLOBAL ANTI-NUCLEAR ANTIBODY TEST MARKET, COMPANY LANDSCAPE 220
11.1. COMPANY SHARE ANALYSIS: GLOBAL
11.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3. COMPANY SHARE ANALYSIS: EUROPE
11.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC

Chapter 12. COMPANY PROFILES
12.1. THERMO FISHER SCIENTIFIC INC.
12.2. MERCK KGAA
12.3. ALERE INC.
12.4. TRINITY BIOTECH
12.5. ANTIBODIES INC.
12.6. BIO-RAD LABORATORIES, INC.

13. RELATED REPORTS

Download Detail Table of Content Visit @ databridgemarketresearch.com/toc/?dbmr=global-antinuclear...

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1388327 • Views: 503
More releasesMore releases

You can edit or delete your press release here: